Authors

• Benjamín Camacho
• Nikolaos Bonaros (ORCID: https://orcid.org/0000-0002-7656-5812)
• Sébastien Hecht (ORCID: https://orcid.org/0000-0002-5408-8576)
• W.A. Wesselink (ORCID: https://orcid.org/0000-0001-6494-2919)
• Carlos Giuliani (ORCID: https://orcid.org/0000-0002-3157-4598)
• Iria Silva
• Alexis Théron (ORCID: https://orcid.org/0000-0001-9453-9039)
• Radka Rakova (ORCID: https://orcid.org/0009-0000-5151-7542)
• Abdellaziz Dahou
• Antonela Zanuttini (ORCID: https://orcid.org/0009-0004-4912-4335)
• Jan Mareš (ORCID: https://orcid.org/0000-0002-4727-3685)
• Peter Bramlage
• Tchetche Didier
• the RHEIA Trial Investigators
• Alberto Alperi
• Philippe Pibarot
• Hélène Eltchaninoff
• David Messika‐Zeitoun
• Stephan Windecker
• Jeroen J Bax

Institutions

• University of Bern (CH)
• Harvard University (US)
• Innsbruck Medical University (AT)
• University of Ottawa (CA)
• Inserm (FR)
• Universität Innsbruck (AT)
• Leiden University Medical Center (NL)
• Assistance Publique Hôpitaux de Marseille (FR)
• Massachusetts General Hospital (US)
• IPPMed (Germany) (DE)
• St. Francis Hospital (US)
• Normandie Université (FR)
• Hospital Arnau de Vilanova (ES)
• Institute of Clinical and Experimental Medicine (CZ)
• Clinique Pasteur (FR)
• Edwards Lifesciences (United States) (US)
• Instituto de Investigación Sanitaria del Principado de Asturias (ES)
• Université Laval (CA)
• Université de Rouen Normandie (FR)
• Edwards Lifesciences (Switzerland) (CH)

Publication Details

Journal

Journal of the American Heart Association

Published

2025-12-30

DOI

https://doi.org/10.1161/jaha.125.047196

Citations

1

Primary Topic

Cardiac Valve Diseases and Treatments

Type

article

Field-Weighted Citation Impact

1.39